 |
About Gateway Pharma |
Gateway Pharma was founded by Philip Huxley. Philip has 18 years experience in the pharmaceutical industry and has played a key role in the identification of four clinical candidates. He began his career as a computational chemist with Novartis (Basel) and has subsequently held positions of increasing seniority with British Biotech (Head of Molecular Design), Avidex (Head of Drug Discovery), and Galapagos Genomics (Director of Drug Discovery). Philip has a successful track record managing multidisciplinary teams combining resource from different disciplines and companies. At Galapagos Philip established the collaboration between Galapagos and Biofocus, which culminated in the merger of the two companies to form a combined group offering integrated Target and Drug Discovery services. Philip has published over 30 scientific articles and patents.
Gateway Pharma is focused on translational research: turning basic science and early stage drug discovery projects into clinical candidates with data packages supporting safety, efficacy and in vivo proof of principle. We have a successful track record in lead identification, library synthesis, SAR exploration and the identification and discovery of compounds with pharmaceutical and pharmacokinetic properties suitable for clinical dev elopement.
